Personal Human lmmune System Mice: Accelerating the Translation of lmmuno-therapies from Bench to Bedside

Register Link:

https://www.eventbrite.com/e/genobiotx-february-2025-webinar-tickets-1228646116609?aff=oddtdtcreator

Date:

  • Wednesday, Feb. 26th, 2025; 2:00 pm EST or 11:00 am PST

Meet Our Speaker:

Dr. Huang earned a Ph.D. in 2004 from the Institute of Zoology, Chinese Academy of Sciences, followed by a postdoctoral fellowship at Peking University Health Science Center (2004–2006). Dr. Huang has dedicated over 15 years to groundbreaking research in the United States at prestigious institutions, including Albert Einstein College of Medicine, the Aaron Diamond AIDS Research Center, Rockefeller University, and Columbia University. A member of Sigma Xi, the Genetics Society of America, and the American Geriatrics Society, Dr. Huang has authored more than 30 peer-reviewed papers in esteemed journals such as Science Translational Medicine and Frontiers in Immunology. Their research focuses on tumor immunology, vaccines, infectious diseases, and animal model development. In 2019, Dr. Huang] founded Genomab Biotech (www.genomab.com) in New York, where they serve as CEO. In 2021, they further expanded their vision by establishing NexVivo Biotech in Suzhou, China, advancing innovation in the biotech industry globally.

About GenoBioTX

GenoBioTX provides comprehensive animal modeling services, ranging from model construction to preclinical in vitro and in vivo assays, based on the combination of versatile technical platforms and experienced scientist.

Contact us

Website: www.genobiotx.com
Email: info@genobiotx.com
Address: 10410 Corporate Dr., Sugar Land, TX, 77478, USA

    News Center

    2024.11.09

    Advancing Cancer Therapy: Harnessing In Vivo Tumor Models for Breakthrough Drug Development

    Registration link: https://www.eventbrite.com/e/1021029977147?aff=oddtdtcreator Date: Wednesday, Oct 2nd, 2024; 11:00 am PST, or 2:00 pm EST Webinar Highlights: Join us for an insightful webinar exploring the critical role of in vivo tumor models in advancing cancer drug therapy. We will provide an overview of the diverse tumor models developed by our company, highlighting case studies demonstrating […]

    2024.11.01

    How to Verify Your Cre-lox Model

    Now that the genetically engineered mice that carry a Cre-conditional (“floxed”) allele in target gene are at your hand. And the mice are supposed to express Cre in target tissue. The validation of your Cre-lox model become very indispensable, so here we advise you of some essential steps. Genotype the mice When unexpected phenotypes are observed during your working with mice, the […]

    Email Back to top